MedTrace Logo

Evaluation of the Effect of Different Biomaterials on Palatal Wound Healing.

NCT07072182 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-07-18

No results posted yet for this study

Summary

All study subjects will sign written informal consent form before enrolment.

They will be divided into four groups, 10 patients each:

* Group I: Palatal wound will be left to heal spontaneously,
* Group II: Palatal wound will be covered with Composite stent,
* Group III: Palatal wound will be covered with PRF,
* Group IV: Palatal wound will be covered with Ora-aid patch. III- Surgical Procedures: -
* After harvesting the palatal soft tissue graft with the standardized dimensions (12 × 7 mm) of the graft for all patients. Graft thickness was standardized as well to be approximately 1.5 to 2 mm and confirmed with a caliper at 3 points (ends and centre of the graft). Fixing of the graft at the recipient site will be performed, back to the donor site for management, the blood clot will be wiped with gauze, then placement of different materials according to each group.
* The dressing will be then pressed gently for 10 seconds, to aid its adherence to the wound. Fixation of the patch will be followed, using 5/0 propylene suture, with performing sling horizontal figure eight suture technique.

Conditions

  • Heal Wound
  • VAS Will be Used to Assess Pain Postoperative

Interventions

DEVICE

Palatal wound will be covered with Ora-aid patch

Palatal wound will be covered with Ora-aid patch

DEVICE

Palatal wound will be covered with Composite stent

Palatal wound will be covered with Composite stent

COMBINATION_PRODUCT

Palatal wound will be covered with PRF

Palatal wound will be covered with PRF

Sponsors & Collaborators

  • Fatma saad saad mahmoud elsherbini

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-20
Primary Completion
2025-05-20
Completion
2025-06-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07072182 on ClinicalTrials.gov